APR 25, 2024

White paper: Integrating pharmacogenomics into the standard of care

WRITTEN BY: Sarah Hoffman

Pharmacogenomics (PGx) can lead to better overall quality of care by making sure that medications are prescribed with the specific individual in mind, rather than guessing what may work best under the “standard of care” paradigm.

PGx helps provide a better understanding of how variations in key areas of an individual's genome may impact the efficacy of a medication, dosage considerations, and potential adverse drug reactions (ADRs). Thus, PGx has become a vital piece of the overall healthcare puzzle.

Download the whitepaper “Integrating pharmacogenomics into the standard of care” to learn more about the implementation hurdles that need to be overcome, as well as PGx tools that are readily available now.